Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Dag Hammarskjöldsväg 20, 75185, Uppsala, Sweden.
Integrated Cardio Metabolic Centre (ICMC), Department of Medicine Huddinge, Karolinska Institutet, Novum, Blickagången 6, 141 57, Huddinge, Sweden.
Transgenic Res. 2020 Feb;29(1):53-68. doi: 10.1007/s11248-019-00177-8. Epub 2019 Oct 22.
The CreER/loxP system is widely used to induce conditional gene deletion in mice. One of the main advantages of the system is that Cre-mediated recombination can be controlled in time through Tamoxifen administration. This has allowed researchers to study the function of embryonic lethal genes at later developmental timepoints. In addition, CreER mouse lines are commonly used in combination with reporter genes for lineage tracing and mosaic analysis. In order for these experiments to be reliable, it is crucial that the cell labeling approach only marks the desired cell population and their progeny, as unfaithful expression of reporter genes in other cell types or even unintended labeling of the correct cell population at an undesired time point could lead to wrong conclusions. Here we report that all CreER mouse lines that we have studied exhibit a certain degree of Tamoxifen-independent, basal, Cre activity. Using Ai14 and Ai3, two commonly used fluorescent reporter genes, we show that those basal Cre activity levels are sufficient to label a significant amount of cells in a variety of tissues during embryogenesis, postnatal development and adulthood. This unintended labelling of cells imposes a serious problem for lineage tracing and mosaic analysis experiments. Importantly, however, we find that reporter constructs differ greatly in their susceptibility to basal CreER activity. While Ai14 and Ai3 easily recombine under basal CreER activity levels, mTmG and R26R-EYFP rarely become activated under these conditions and are therefore better suited for cell tracking experiments.
CreER/loxP 系统被广泛用于诱导小鼠条件性基因缺失。该系统的主要优势之一是,通过给予他莫昔芬,可实现 Cre 介导的重组的时间控制。这使得研究人员能够在稍后的发育时间点研究胚胎致死基因的功能。此外,CreER 小鼠品系通常与报告基因结合用于谱系追踪和嵌合体分析。为了使这些实验可靠,至关重要的是细胞标记方法仅标记所需的细胞群体及其后代,因为报告基因在其他细胞类型中的不忠实表达,甚至在不期望的时间点对正确的细胞群体进行不期望的标记,都可能导致错误的结论。在这里,我们报告说,我们研究的所有 CreER 小鼠品系都表现出一定程度的 Tamoxifen 非依赖性、基础 Cre 活性。使用两种常用的荧光报告基因 Ai14 和 Ai3,我们表明这些基础 Cre 活性水平足以在胚胎发生、出生后发育和成年期的各种组织中标记大量细胞。这种对细胞的意外标记给谱系追踪和嵌合体分析实验带来了严重的问题。然而,重要的是,我们发现报告基因构建体在对基础 CreER 活性的敏感性方面存在很大差异。虽然 Ai14 和 Ai3 在基础 CreER 活性水平下容易重组,但 mTmG 和 R26R-EYFP 在这些条件下很少被激活,因此更适合用于细胞跟踪实验。